echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The salary of the CEO of the new crown vaccine manufacturer has soared!

    The salary of the CEO of the new crown vaccine manufacturer has soared!

    • Last Update: 2021-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CompileKe Ke

    The lockdown and work interruption caused by the COVID-19 pandemic affect the global economy.


    The foreign media BioSpace website pays attention to the annual salary of vaccine developer CEO:

    Pfizer: Albert Bourla

    Pfizer: Albert Bourla

    Pfizer CEO Bora will make a net profit of US$21 million in 2020 because his company has cooperated with German BioNTech and became the first company to obtain emergency use authorization for the COVID-19 vaccine in the United States.


    According to Bloomberg's analysis of Bora's compensation, the overall compensation plan for 2020 is an increase of 17% over his 2019 compensation plan.


    The vaccine developed by Pfizer and BioNTech was approved in December last year and is 95% effective against the virus.


    BioNTech: Ugur Sahin

    BioNTech: Ugur Sahin

    BioNTech CEO Sahin received a total salary of US$7.


    According to Bloomberg News, Sahin is the sole shareholder of the German company, which controls 18% of BioNTech.


    Moderna: St.


    Moderna: St.


    According to SEC documents, Bansell’s basic salary is $950,000.


    Moderna is evaluating its vaccine for minors, as well as a vaccine for the emerging new strain of coronavirus.


    Johnson & Johnson: Alex Gorsky

    Johnson & Johnson: Alex Gorsky

    Gorski, chairman and CEO of life science giant Johnson & Johnson, received $25,365,800 in revenue in 2020.


    Johnson & Johnson's single-dose vaccine was approved by the US FDA in March.


    AstraZeneca: Pascal Soriot

    AstraZeneca: Pascal Soriot

    In 2020, Soriot received an annual salary of $21.


    AstraZeneca’s vaccine is not authorized for use in the United States, but has been approved in Europe, South America and parts of Asia.


    Article reference source:

    CEOs of COVID-19 Vaccine Makers See Boost in Salaries

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.